Welcome to LookChem.com Sign In|Join Free
  • or
(3S)-3-benzyl-7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one is a complex organic compound belonging to the benzodiazepine class. It features a seven-membered diazepine ring with a chlorine atom at the 7th position, a phenyl group at the 5th position, and a benzyl group attached to the 3rd position of the diazepine ring. (3S)-3-benzyl-7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one is known for its potential sedative and anxiolytic properties, similar to other benzodiazepines, which are commonly used as central nervous system depressants.

39200-49-2

Post Buying Request

39200-49-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

39200-49-2 Usage

Uses

Used in Pharmaceutical Industry:
(3S)-3-benzyl-7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one is used as a potential therapeutic agent for the treatment of anxiety and insomnia. Its chemical structure and benzodiazepine classification suggest that it may possess anxiolytic and sedative properties, which could be beneficial in managing these conditions. However, further research and testing are required to confirm its specific pharmacological effects and therapeutic potential.
Used in Research and Development:
(3S)-3-benzyl-7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one is also used in the research and development of new drugs and therapies. Its structural similarity to other benzodiazepines makes it a valuable tool for studying the mechanisms of action and potential side effects of these drugs. Additionally, it may serve as a starting point for the design and synthesis of novel benzodiazepine-based medications with improved efficacy and reduced side effects.
Used in Neurological Applications:
(3S)-3-benzyl-7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one may be used as a potential treatment for neurological disorders such as seizures, due to the known sedative and anxiolytic properties of benzodiazepines. Its potential use in this application is based on the ability of benzodiazepines to modulate the activity of gamma-aminobutyric acid (GABA) receptors in the central nervous system, which play a crucial role in controlling neuronal excitability and seizure activity.

Check Digit Verification of cas no

The CAS Registry Mumber 39200-49-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,2,0 and 0 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 39200-49:
(7*3)+(6*9)+(5*2)+(4*0)+(3*0)+(2*4)+(1*9)=102
102 % 10 = 2
So 39200-49-2 is a valid CAS Registry Number.

39200-49-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (3S)-3-benzyl-7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:39200-49-2 SDS

39200-49-2Relevant academic research and scientific papers

An Atom-Economical Method to Prepare Enantiopure Benzodiazepines with N-Carboxyanhydrides

Fier, Patrick S.,Whittaker, Aaron M.

supporting information, p. 1454 - 1457 (2017/03/23)

The development of a rapid, one-pot synthesis of diazepinones with simple reagents is described. N-Carboxyanhydrides (NCAs) are employed as amino acid building blocks that react with o-ketoanilines sequentially as electrophiles and nucleophiles to form diazepinones with water and carbon dioxide as byproducts. Notably, these reactions enable the coupling of stereodefined amino acid derived NCAs without racemization. This method is demonstrated by an improved synthesis of a key intermediate toward a bromodomain and extra-terminal (BET) bromodomain inihibitor.

Discrimination between enantiomers of structurally related molecules: Separation of benzodiazepines by molecularly imprinted polymers

Hart, Bradley R.,Rush, Daniel J.,Shea, Kenneth J.

, p. 460 - 465 (2007/10/03)

Molecular imprinting has been used to create synthetic receptor sites for a series of chiral benzodiazepines. A detailed HPLC analysis of binding properties using molecularly imprinted polymers (MIPs) as the stationary phase showed that binding, as measur

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 39200-49-2